The Global Stem Cell Therapy Market is set to witness a healthy growth rate of 20% by 2029. A favorable investment ...

The advent of induced pluripotent stem cells (iPSCs) could be key to addressing this challenge, with iPSCs offering the potential for self-renewal and pluridirectional differentiation. iPSCs can ...

With its wealth of experience, Creative Biolabs stands ready to support global researchers in advancing their iPSC-derived cell therapy studies.

Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank Mesoblast for inspiring the third.

Cellino, a leader in advanced biomanufacturing, today announced that its optical biomanufacturing technology for generating ...

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

Duke University Medical Center-led research has identified a human-specific DNA enhancer that regulates neural progenitor ...

Imec and Merck have announced a strategic partnership to develop an advanced MicroPhysiological Systems (MPS) platform.

Well known Tamil actress Vidya Pradeep, who after completing her doctorate in Stem cell biology, left for the US for a ...

This designation highlights the potential of Cellino’s automated technology for scaling up high-quality iPSCs to industrialize next-generation regenerative therapies. Autologous ...

LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for ...

The northern white rhinoceros is one of the rarest animals on Earth, with just two females left and no natural way for the ...